Key result
A single 1 g pulse of methylprednisolone provided clinical benefit prolonged beyond 3 weeks in patients with active rheumatoid arthritis, whereas and doses were not helpful.
Why the study?
Does high-dose pulsed methylprednisolone (500 mg or 1 g) improve clinical benefit compared to low-dose (40 mg) in patients with active early rheumatoid disease?
RCT (n=71)
Double-blind
Does high-dose pulsed methylprednisolone (500 mg or 1 g) improve clinical benefit compared to low-dose (40 mg) in patients with active early rheumatoid disease?
Single doses of pulsed methylprednisolone below 1 g are not helpful for achieving prolonged clinical benefit in the management of acute rheumatoid arthritis.
Answers are grounded in this paper and cite their sources.
Supports 1 g methylprednisolone pulses for prolonged benefit in active RA; confirms lower doses lack efficacy.
A dose-ranging, double-blind study of pulsed methylprednisolone in 71 patients with active classical or definite RA is reported. Single pulses of 40 mg, 500 mg or 1 g were administered during a 24-h admission. All patients benefited transiently, but only in those who received 1 g was this prolonged beyond 3 weeks. Laboratory measurements showed no significant change in any group. Significantly more patients in the 1 g group felt the treatment worthwhile than in the other groups. The drop-out rates in the 40 mg and 500 mg groups differed significantly from that seen in the 1 g group and were such that statistical analysis beyond 3 weeks was difficult to interpret. Side-effects were mild. Three patients subsequently developed avascular necrosis, one in the 1 g and two in the 40 mg groups. The study suggests that single doses of MP below 1 g are not helpful in the management of acute RA.
No takes yet. Share an insight, caveat, or question.
Shipley et al. (1988) conducted an RCT in Active classical or definite rheumatoid arthritis (n=71). Pulsed methylprednisolone vs. Different doses compared against each other was evaluated on Clinical benefit prolonged beyond 3 weeks. A single 1 g pulse of methylprednisolone provided clinical benefit prolonged beyond 3 weeks in patients with active rheumatoid arthritis, whereas and doses were not helpful.
Synapse has enriched 10 related papers. Consider them for comparative context: